Australis Capital Inc. (AUSAF)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
-0.0009 (-90.00%)
At close: Mar 5, 2026
Australis Capital Revenue
In the fiscal year ending March 31, 2022, Australis Capital had annual revenue of 9.47M CAD with 1,221.13% growth. Australis Capital had revenue of 3.10M in the quarter ending March 31, 2022, with 575.81% growth.
Revenue
9.47M CAD
Revenue Growth
+1,221.13%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
25.42K USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Filament Health | 329.20K |
| Real Brands | 38.21K |
| Anbc, Inc. | 50.95K |
| Wuhan General Group (China) | 80.38M |
| Marijuana Company of America | 1.50M |
| Western Sierra Resource | 1.20M |
| Acura Pharmaceuticals | 1.56M |
| EVIO, Inc. | 2.36M |